levofloxacin has been researched along with Healthcare-Associated Pneumonia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheong, HJ; Hyun, H; Kim, WJ; Noh, JY; Seong, H; Song, JY; Yoon, JG | 1 |
1 other study(ies) available for levofloxacin and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Healthcare-Associated Pneumonia; Hospitals; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Pseudomonas aeruginosa; Retrospective Studies; Risk Factors | 2022 |